Related Experiment Video
Updated: May 3, 2026
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Kv7 channels as targets for anti-epileptic and psychiatric drug-development
Morten Grunnet1, Dorte Strøbæk2, Charlotte Hougaard2
1Lundbeck Pharma A/S, Ottiliavej 9 Valby, DK2500, Denmark.
Abstract:
The Kv7 channels, a family of voltage-dependent K(+) channels (Kv7.1-Kv7.5), have gained much attention in drug discovery especially because four members are genetically linked to diseases. For disorders of the CNS focus was originally on epilepsy and pain, but it is becoming increasingly evident that Kv7 channels can also be valid targets for psychiatric disorders, such as anxiety and mania. The common denominator is probably neuronal hyperexcitability in different brain areas, which can be successfully attenuated by pharmacological increment of Kv7 channel activity. This perspective attempts to review the current status and challenges for CNS drug discovery based on Kv7 channels as targets for neurological and psychiatric indications with special focus on selectivity and mode-of-actions.
Insights
Kv7 channels are crucial drug targets for CNS disorders, including epilepsy, pain, anxiety, and mania. Enhancing Kv7 channel activity effectively reduces neuronal hyperexcitability for neurological and psychiatric indications.
Area of Science:
- Neuroscience
- Pharmacology
- Channelopathies
Background:
- Kv7 channels (Kv7.1-Kv7.5) are voltage-dependent potassium channels implicated in various physiological processes.
- Genetic links exist between Kv7 channel dysfunction and several human diseases.
- These channels are increasingly recognized as therapeutic targets for central nervous system (CNS) disorders.
Purpose of the Study:
- To review the current landscape of CNS drug discovery targeting Kv7 channels.
- To highlight the potential of Kv7 channels for neurological and psychiatric indications.
- To discuss challenges related to selectivity and mode-of-action for Kv7-based therapeutics.
Main Methods:
- Literature review and synthesis of existing research on Kv7 channels in CNS disorders.
- Analysis of genetic data linking Kv7 channel mutations to diseases.
- Examination of pharmacological strategies aimed at modulating Kv7 channel activity.
Main Results:
- Kv7 channels are implicated in neuronal hyperexcitability, a common factor in epilepsy, pain, anxiety, and mania.
- Pharmacological enhancement of Kv7 channel function shows promise in attenuating neuronal hyperexcitability.
- Four specific Kv7 channel subtypes are genetically associated with various diseases.
Conclusions:
- Kv7 channels represent a significant target class for developing novel CNS therapeutics.
- Achieving selectivity and understanding precise modes-of-action are key challenges for Kv7-based drug discovery.
- Further research is warranted to fully exploit the therapeutic potential of Kv7 channels for neurological and psychiatric conditions.
Related Concept Videos
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:24Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...